Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer.

Zhang X, Liu H, Balter P, Allen PK, Komaki R, Pan T, Chuang HH, Chang JY.

Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1558-65. doi: 10.1016/j.ijrobp.2011.10.035. Epub 2012 May 7.

3.

Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer.

Larici AR, del Ciello A, Maggi F, Santoro SI, Meduri B, Valentini V, Giordano A, Bonomo L.

Radiographics. 2011 May-Jun;31(3):771-89. doi: 10.1148/rg.313105096. Review.

PMID:
21571656
4.

[Assessment of the response following stereotactic irradiation of lung primary tumors and metastases].

Barillot I, Munier O, Hatime M, Mornex F.

Cancer Radiother. 2014 Jul-Aug;18(4):308-12. doi: 10.1016/j.canrad.2013.12.010. Epub 2014 Apr 18. Review. French.

PMID:
24746763
5.

Is computed tomography follow-up of patients after lobectomy for non-small cell lung cancer of benefit in terms of survival?

Srikantharajah D, Ghuman A, Nagendran M, Maruthappu M.

Interact Cardiovasc Thorac Surg. 2012 Nov;15(5):893-8. doi: 10.1093/icvts/ivs342. Epub 2012 Aug 1. Review.

6.

Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.

Loganadane G, Martinetti F, Mercier O, Krhili S, Riet FG, Mbagui R, To H, Le Péchoux C, Levy A.

Cancer Treat Rev. 2016 Nov;50:240-246. doi: 10.1016/j.ctrv.2016.10.002. Epub 2016 Oct 13. Review.

PMID:
27768919
7.

Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria.

Caulo A, Mirsadraee S, Maggi F, Leccisotti L, van Beek EJ, Bonomo L.

Eur Radiol. 2012 Mar;22(3):588-606. doi: 10.1007/s00330-011-2299-8. Epub 2011 Oct 4. Review.

PMID:
21969110
8.

[Radiological evaluation of the tumour response after lung stereotactic radiotherapy].

Vulquin N, Feutray S, Peignaux-Casasnovas K, Humbert O, Créhange G, Truc G, Maingon P, Martin E.

Cancer Radiother. 2014 Oct;18(5-6):414-9. doi: 10.1016/j.canrad.2014.07.157. Epub 2014 Sep 16. Review. French.

PMID:
25199864
9.

[Follow-up after lung stereotactic radiotherapy].

Waissi W, Noël G, Giraud P.

Cancer Radiother. 2015 Oct;19(6-7):566-72. doi: 10.1016/j.canrad.2015.05.004. Epub 2015 Aug 31. Review. French.

PMID:
26337472
10.

PET-CT use and the occurrence of elective nodal failure in involved field radiotherapy for non-small cell lung cancer: A systematic review.

Kepka L, Socha J.

Radiother Oncol. 2015 May;115(2):151-6. doi: 10.1016/j.radonc.2015.04.001. Epub 2015 Apr 17. Review.

PMID:
25892612
11.

Metabolic imaging in non-small-cell lung cancer radiotherapy.

Geets X, Sterpin E, Wanet M, Di Perri D, Lee J.

Cancer Radiother. 2014 Oct;18(5-6):402-5. doi: 10.1016/j.canrad.2014.07.146. Epub 2014 Aug 29. Review.

PMID:
25179249
12.

[Highly conformal radiotherapy of primary and secondary lung malignancies].

Schanne D, Feldmann HJ, Nestle U.

MMW Fortschr Med. 2013 Jul 25;155(13):41-3. Review. German. No abstract available.

PMID:
23964506
13.

Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete?

Dupuy DE.

J Vasc Interv Radiol. 2013 Aug;24(8):1139-45. doi: 10.1016/j.jvir.2013.04.021. Epub 2013 Jun 21. Review.

PMID:
23796858
14.

Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients.

Ceniceros L, Aristu J, Castañón E, Rolfo C, Legaspi J, Olarte A, Valtueña G, Moreno M, Gil-Bazo I.

Clin Transl Oncol. 2016 Mar;18(3):259-68. doi: 10.1007/s12094-015-1361-4. Epub 2015 Aug 5. Review.

PMID:
26243396
15.

Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.

Wink KCJ, van Baardwijk A, Troost EGC, De Ruysscher D.

Cancer Treat Rev. 2017 May;56:8-15. doi: 10.1016/j.ctrv.2017.04.001. Epub 2017 Apr 12. Review.

PMID:
28437679
16.

The use and misuse of positron emission tomography in lung cancer evaluation.

Chang CF, Rashtian A, Gould MK.

Clin Chest Med. 2011 Dec;32(4):749-62. doi: 10.1016/j.ccm.2011.08.012. Review.

17.

The evolving role of molecular imaging in non-small cell lung cancer radiotherapy.

MacManus M, Everitt S, Hicks RJ.

Semin Radiat Oncol. 2015 Apr;25(2):133-42. doi: 10.1016/j.semradonc.2014.12.001. Epub 2014 Dec 15. Review.

PMID:
25771418
18.

Radiofrequency ablation for early-stage nonsmall cell lung cancer.

Hiraki T, Gobara H, Iguchi T, Fujiwara H, Matsui Y, Kanazawa S.

Biomed Res Int. 2014;2014:152087. doi: 10.1155/2014/152087. Epub 2014 Jun 3. Review.

19.

[Positron emission tomography and stereotactic body radiation therapy for lung cancer: From treatment planning to response evaluation].

Bibault JE, Oudoux A, Durand-Labrunie J, Mirabel X, Lartigau É, Kolesnikov-Gauthier H.

Cancer Radiother. 2015 Dec;19(8):790-4; quiz 795-9. doi: 10.1016/j.canrad.2015.05.027. Epub 2015 Oct 21. Review. French.

PMID:
26476702
20.

The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.

Guerrero E, Ahmed M.

Lung Cancer. 2016 Feb;92:22-8. doi: 10.1016/j.lungcan.2015.11.015. Epub 2015 Dec 2. Review.

PMID:
26775592

Supplemental Content

Support Center